Search

Author/Creator Hellmis, Eva

1. Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma. (March 2022)

Authors:
Sonpavde, Guru P.; Sternberg, Cora N.; Loriot, Yohann; Marabelle, Aurelien; Lee, Jae Lyun; Fléchon, Aude; Roubaud, Guilhem; Pouessel, Damien; Zagonel, Vittorina; Calabro, Fabio; Banna, Giuseppe L.; Shin, Sang Joon; Vera-Badillo, Francisco E.; Powles, Thomas; Hellmis, Eva; Miranda, Paulo A.P.; Lim...
Journal:
European journal of cancer
Issue:
Volume 163(2022)
Page Start:
55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search